Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family.
Fox CB, Van Hoeven N, Granger B, Lin S, Guderian JA, Hartwig A, Marlenee N, Bowen RA, Soultanov V, Carter D. Fox CB, et al. Among authors: bowen ra. Phytomedicine. 2019 Nov;64:152927. doi: 10.1016/j.phymed.2019.152927. Epub 2019 Apr 12. Phytomedicine. 2019. PMID: 31465981 Free PMC article.
Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
Stavaru C, Onu A, Lupulescu E, Tucureanu C, Rasid O, Vlase E, Coman C, Caras I, Ghiorghisor A, Berbecila L, Tofan V, Bowen RA, Marlenee N, Hartwig A, Bielefeldt-Ohmann H, Baldwin SL, Van Hoeven N, Vedvick TS, Huynh C, O'Hara MK, Noah DL, Fox CB. Stavaru C, et al. Among authors: bowen ra. Hum Vaccin Immunother. 2016 Apr 2;12(4):1009-26. doi: 10.1080/21645515.2015.1111495. Epub 2015 Nov 30. Hum Vaccin Immunother. 2016. PMID: 26618392 Free PMC article.
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.
Van Hoeven N, Fox CB, Granger B, Evers T, Joshi SW, Nana GI, Evans SC, Lin S, Liang H, Liang L, Nakajima R, Felgner PL, Bowen RA, Marlenee N, Hartwig A, Baldwin SL, Coler RN, Tomai M, Elvecrog J, Reed SG, Carter D. Van Hoeven N, et al. Among authors: bowen ra. Sci Rep. 2017 Apr 21;7:46426. doi: 10.1038/srep46426. Sci Rep. 2017. PMID: 28429728 Free PMC article.
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
Van Hoeven N, Joshi SW, Nana GI, Bosco-Lauth A, Fox C, Bowen RA, Clements DE, Martyak T, Parks DE, Baldwin S, Reed SG, Coler RN. Van Hoeven N, et al. Among authors: bowen ra. PLoS One. 2016 Feb 22;11(2):e0149610. doi: 10.1371/journal.pone.0149610. eCollection 2016. PLoS One. 2016. PMID: 26901122 Free PMC article.
Adjuvant solution for pandemic influenza vaccine production.
Clegg CH, Roque R, Van Hoeven N, Perrone L, Baldwin SL, Rininger JA, Bowen RA, Reed SG. Clegg CH, et al. Among authors: bowen ra. Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17585-90. doi: 10.1073/pnas.1207308109. Epub 2012 Oct 8. Proc Natl Acad Sci U S A. 2012. PMID: 23045649 Free PMC article.
310 results